IIM
ALXN

Intact Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Intact Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,400
Closed -$687K – 261
2020
Q4 		$687K Sell
4,400
-3,400
-44% -$437K 0.02% 212
2020
Q3 		$892K Hold
7,800
– – 0.03% 189
2020
Q2 		$874K Sell
7,800
-1,000
-11% -$106K 0.03% 191
2020
Q1 		$790K Buy
8,800
+1,600
+22% +$157K 0.03% 182
2019
Q4 		$778K Buy
7,200
+3,600
+100% +$385K 0.03% 195
2019
Q3 		$353K Hold
3,600
– – 0.01% 211
2019
Q2 		$472K Hold
3,600
– – 0.02% 196
2019
Q1 		$487K Hold
3,600
– – 0.02% 191
2018
Q4 		$351K Sell
3,600
-1,400
-28% -$165K 0.01% 192
2018
Q3 		$695K Sell
5,000
-300
-6% -$37.6K 0.02% 173
2018
Q2 		$658K Hold
5,300
– – 0.02% 169
2018
Q1 		$591K Sell
5,300
-200
-4% -$23.9K 0.02% 168
2017
Q4 		$658K Buy
5,500
+400
+8% +$48.7K 0.03% 140
2017
Q3 		$715K Sell
5,100
-2,100
-29% -$285K 0.03% 142
2017
Q2 		$876K Buy
7,200
+1,900
+36% +$221K 0.04% 134
2017
Q1 		$643K Sell
5,300
-1,300
-20% -$168K 0.03% 147
2016
Q4 		$808K Buy
6,600
+4,700
+247% +$575K 0.03% 165
2016
Q3 		$233K Buy
+1,900
New +$245K 0.01% 256
2016
Q2 		– Sell
-1,500
Closed -$209K – 291
2016
Q1 		$209K Buy
1,500
+300
+25% +$44K 0.01% 261
2015
Q4 		$229K Buy
+1,200
New +$210K 0.01% 231

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Intact Investment Management's ALXN Position: Q1 2021 in Review

Intact Investment Management sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 4,400 shares — an estimated $687K sold.

Intact Investment Management first reported a position in ALXN in Q4 2015 and held it in 20 quarters. The position peaked at $892K in Q3 2020. 754 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

  • Intact Investment Management reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Intact Investment Management sold 4,400 Alexion Pharmaceuticals shares in Q1 2021, an estimated $687K.
  • Intact Investment Management first reported a position in Alexion Pharmaceuticals in Q4 2015 and held it in 20 quarters.
  • Intact Investment Management's Alexion Pharmaceuticals position peaked at $892K in Q3 2020.
  • 754 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Intact Investment Management's 13F filing for Q1 2021, filed 17 May 2021.